Shots:
The US FDA has accepted IND application for LEVI-04 for the treatment of osteoarthritis
Levicept has completed the P-II trial of LEVI-04 in 518 patients with pain & disability due to knee OA, with ACR Convergence data showing the 1EP was met & demonstrated significant analgesia & symptom control across all doses
Further analyses…
